{"filing":{"accession_number":"0001477932-26-004244","cik":"0001096938","ticker":"UEEC","company_name":"United Health Products, Inc.","form":"8-K","filing_date":"2026-07-10","report_date":null,"primary_document":"ueec_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1096938/000147793226004244/ueec_8k.htm"},"events":[{"id":17279,"run_id":15461,"accession_number":"0001477932-26-004244","anchor_item_number":"8.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"United Health Products announced an agreement with NAMSA, a contract research organization, to serve as regulatory sponsor of a clinical study for CelluSTAT Hemostatic Gauze in connection with the company's FDA Premarket Approval application. This is a material operational and strategic milestone—the establishment of a collaboration to advance a critical product through FDA approval—but does not fit the specific categories of M\u0026A activity, debt issuance, workforce reduction, or other named event types. The disclosure centers on a material business partnership and regulatory strategy development.","company_name":"United Health Products, Inc.","ticker":"UEEC","filing_date":"2026-07-10","form":"8-K","submitted_at":null,"items":[{"id":15655,"accession_number":"0001477932-26-004244","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"United Health Products announced an agreement with NAMSA, a contract research organization, to serve as regulatory sponsor of a clinical study for CelluSTAT Hemostatic Gauze in connection with the company's FDA Premarket Approval application. This is a material operational and strategic milestone—the establishment of a collaboration to advance a critical product through FDA approval—but does not fit the specific categories of M\u0026A activity, debt issuance, workforce reduction, or other named event types. The disclosure centers on a material business partnership and regulatory strategy development.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T16:20:39.510755+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15655,"accession_number":"0001477932-26-004244","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"United Health Products announced an agreement with NAMSA, a contract research organization, to serve as regulatory sponsor of a clinical study for CelluSTAT Hemostatic Gauze in connection with the company's FDA Premarket Approval application. This is a material operational and strategic milestone—the establishment of a collaboration to advance a critical product through FDA approval—but does not fit the specific categories of M\u0026A activity, debt issuance, workforce reduction, or other named event types. The disclosure centers on a material business partnership and regulatory strategy development.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T16:20:39.510755+00:00","company_name":"United Health Products, Inc.","ticker":"UEEC","filing_date":"2026-07-10"}]}